Hearty risk management yields healthy dividends
Posted on 04-05-2019 by Lisa Thompson

Most risk management professionals know the adage, “An ounce of prevention is worth a pound of cure.” But in the digital age, you need more than an ounce of prevention when it comes to mitigating regulatory and reputational risk . It’s a lesson learned the hard way by one of the largest... Read More

Why Pharma & Biomed Companies’ Risk Analysis Processes are Due for a Check-Up
Posted on 07-18-2018 by Lisa Thompson

Just three years ago, Teva Pharmaceuticals, a drug-maker in Israel, disclosed to both the U.S. Securities & Exchange Commission and the U.S. Department of Justice that an on-going internal probe had revealed possible violations of the Foreign Corrupt Practices Act (FCPA) and/or local laws. Ultimately... Read More

Effective due diligence the best medicine for the pharmaceutical industry
Posted on 08-12-2015 by Ulyana Androsova

The pharmaceutical industry has been impacted by globalization more than most. Where there was traditionally a significant difference between the levels of healthcare and well-being between the developed and developing worlds, there has been rapid and complex change. With an increased demand for cures... Read More